Preemptive treatment of fungal infection based on plasma (1 → 3)β-D-glucan levels after liver transplantation

Infection

Volumn 35, Issue 5, 2007, Pages 346-351

  Akamatsu, N ^a   Sugawara, Y ^a   Kaneko, J ^a   Tamura, S ^a   Makuuchi, M ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN PLUS CLOXACILLIN; CEFOTAXIME; COTRIMOXAZOLE; FLUCONAZOLE; GENTAMICIN; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; BLOOD LEVEL; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG MEGADOSE; FEMALE; HUMAN; KIDNEY FAILURE; LIVER TRANSPLANTATION; MALE; MORTALITY; MYCOSIS; PNEUMOCYSTIS JIROVECI; POSTOPERATIVE PERIOD; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ANTIFUNGAL AGENTS; BETA-GLUCANS; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOSES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 34848893571     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-6240-7     Document Type: Article

References (37)

1. Castaldo P, Stratta RJ, Wood RP, Markin RS, Patil KD, Shaefer MS, Langnas AN, Reed EC, Li SJ, Pillen TJ: Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991; 126: 149-156.
2. Winston DJ, Emmanouilides C, Busuttil RW: Infections in liver transplant recipients. Clin Infect Dis 1995; 21: 1077-1089.
3. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R: Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995; 21: 1328-1336.
4. Hayes MJ, Torzillo PJ, Sheil AG, McCaughan GW: Pneumocystis carinii pneumonia after liver transplantation in adults. Clin Transplant 1994; 8: 499-503.
5. Hadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM: Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation 1995; 59: 851-859.
6. Husain S, Tollemar J, Dominguez EA, Baumgarten K, Humar A, Paterson DL, Wagener MM, Kusne S, Singh N: Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation 2003; 75: 2023-2029.
7. Singh N, Gayowski T, Wagener MM, Doyle H, Marino IR: Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clin Infect Dis 1997; 24: 179-184.
8. Singh N, Avery RK, Munoz P, Pruett TL, Alexander B, Jacobs R, Tollemar JG, Dominguez EA, Yu CM, Paterson DL, Husain S, Kusne S, Linden P: Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003; 36: 46-52.
9. Pappas PG, Andes D, Schuster M, Hadley S, Rabkin J, Merion RM, Kauffman CA, Huckabee C, Cloud GA, Dismukes WE, Karchmer AW: Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. Am J Transplant 2006; 6: 386-391.
10. Tollemar J, Hockerstedt K, Ericzon BG, Jalanko H, Ringden O: Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients: a randomized, placebo-controlled study. Transplantation 1995; 59: 45-50.
11. Lumbreras C, Cuervas-Mons V, Jara P, del Palacio A, Turrion VS, Barrios C, Moreno E, Noriega AR, Paya CV: Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. J Infect Dis 1996; 174: 583-588.
12. Winston DJ, Pakrasi A, Busuttil RW: Prophylactic fluconazole in liver transplant patients: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 131: 729-737.
13. Torre-Cisneros J, De la Mata M, Pozo JC, Serrano P, Briceno J, Solorzano G, Mino G, Pera C, Sanchez-Guijo P: Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation. Clin Infect Dis 1999; 29: 771-774.
14. Biancofiore G, Bindi ML, Baldassarri R, Romanelli AM, Catalano G, Filipponi F, Vagelli A, Mosca F: Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study. Transpl Int 2002; 15: 341-347.
15. Winston DJ, Busuttil RW: Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients. Transplantation 2002; 74: 688-695.
16. Sharpe MD, Ghent C, Grant D, Horbay GL, McDougal J, David Colby W: Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study. Transplantation 2003; 76: 977-983.
17. Flahaut M, Sanglard D, Monod M, Bille J, Rossier M: Rapid detection of Candida albicans in clinical samples by DNA amplification of common regions from C. albicans-secreted aspartic proteinase genes. J Clin Microbiol 1998; 36: 395-401.
18. Hebart H, Loffler J, Reitze H, Engel A, Schumacher U, Klingebiel T, Bader P, Bohme A, Martin H, Bunjes D, Kern WV, Kanz L, Einsele H: Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia. Br J Haematol 2000; 111: 635-640.
19. Kami M, Fukui T, Ogawa S, Kazuyama Y, Machida U, Tanaka Y, Kanda Y, Kashima T, Yamazaki Y, Hamaki T, Mori S, Akiyama H, Mutou Y, Sakamaki H, Osumi K, Kimura S, Hirai H: Use of realtime PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 2001; 33: 1504-1512.
20. Ferns RB, Fletcher H, Bradley S, Mackinnon S, Hunt C, Tedder RS: The prospective evaluation of a nested polymerase chain reaction assay for the early detection of Aspergillus infection in patients with leukaemia or undergoing allograft treatment. Br J Haematol 2002; 119: 720-725.
21. Yera H, Sendid B, Francois N, Camus D, Poulain D: Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis. Eur J Clin Microbiol Infect Dis 2001; 20: 864-870.
22. Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F: Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001; 91: 311-318.
23. Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, Villard O, Liu KL, Natarajan-Ame S, Lutz P, Dufour P, Bergerat JP, Candolfi E: Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20: 1898-1906.
24. Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M: Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186: 1297-1306.
25. Vilchez R, Shapiro R, McCurry K, Kormos R, Abu-Elmagd K, Fung J, Kusne S: Longitudinal study of cryptococcosis in adult solidorgan transplant recipients. Translp Int 2003; 16: 336-340.
26. Sendid B, Jouault T, Coudriau R, Camus D, Odds F, Tabouret M, Poulain D: Increased sensitivity of mannanemia detection tests by joint detection of alpha- and beta-linked oligomannosides during experimental and human systemic candidiasis. J Clin Microbiol 2004; 42: 164-171.
27. McLintock LA, Jones BL: Advances in the molecular and serological diagnosis of invasive fungal infection in haematooncology patients. Br J Haematol 2004; 126: 289-297.
28. Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A: Plasma (1 → 3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17-20.
29. Yasuoka A, Tachikawa N, Shimada K, Kimura S, Oka S: (1 → 3) β-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia. Clin Diagn Lab Immunol 1996; 3: 197-199.
30. Sugawara Y, Makuuchi M, Kaneko J, Ohkubo T, Imamura H, Kwarasaki H: Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantation. Clin Transplant 2002; 16: 102-106.
31. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer Mycoses Study Group of the National Institute of Allergy and Infectious Diseases: Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
32. Mori T, Ikemoto H, Matsumura M, Mori T, Ikemoto H, Matsumura M, Yoshida M, Inada K, Endo S, Ito A, Watanabe S, Yamaguchi H, Mitsuya M, Kodama M, Tani T, Yokota T, Kobayashi T, Kambayashi J, Nakamura T, Masaoka T, Teshima H, Yoshinaga T, Kohno S, Hara K, Miyazaki S: Evaluation of plasma (1 → 3)-β-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur J Clin Chem Clin Biochem 1997; 35: 553-560.
33. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL: Evaluation of a (1 → 3)-β-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005; 43: 5957-5962.
34. Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA, Rex JH: Multicenter clinical evaluation of the (1 → 3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41: 654-659.
35. Usami M, Ohata A, Horiuchi T, Nagasawa K, Wakabayashi T, Tanaka S: Positive (1 → 3)-β-D-glucan in blood components and release of (1 fi 3)-b-D-glucan from depth-type membrane filters for blood processing. Transfusion 2002; 42: 1189-1195.
36. Kato A, Takita T, Furuhashi M, Takahashi T, Maruyama Y, Hishida A: Elevation of blood (1 → 3)-β-D-glucan concentrations in hemodialysis patients. Nephron 2001; 89: 15-19.
37. Miyazaki T, Kohno S, Mitsutake K, Maesaki S, Tanaka K, Ishikawa N, Hara K: Plasma (1 → 3)-β-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol 1995; 33: 3115-3118.